| Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage T Nishikawa, D Edelstein, XL Du, S Yamagishi, T Matsumura, Y Kaneda, ... Nature 404 (6779), 787-790, 2000 | 5599 | 2000 |
| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4300 | 2020 |
| ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular … Authors/Task Force Members, L Rydén, PJ Grant, SD Anker, C Berne, ... European heart journal 34 (39), 3035-3087, 2013 | 2361 | 2013 |
| Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy HP Hammes, X Du, D Edelstein, T Taguchi, T Matsumura, Q Ju, J Lin, ... Nature medicine 9 (3), 294-299, 2003 | 1216 | 2003 |
| The progress in understanding and treatment of diabetic retinopathy AW Stitt, TM Curtis, M Chen, RJ Medina, GJ McKay, A Jenkins, ... Progress in retinal and eye research 51, 156-186, 2016 | 967 | 2016 |
| Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. HP Hammes, S Martin, K Federlin, K Geisen, M Brownlee Proceedings of the National Academy of Sciences 88 (24), 11555-11558, 1991 | 804 | 1991 |
| Combined inhibition of VEGF‐and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanisms R Erber, A Thurnher, A D. Katsen, G Groth, H Kerger, HP Hammes, ... The FASEB journal 18 (2), 1-25, 2004 | 731 | 2004 |
| Pericytes and the pathogenesis of diabetic retinopathy HP Hammes, J Lin, O Renner, M Shani, A Lundqvist, C Betsholtz, ... Diabetes 51 (10), 3107-3112, 2002 | 713 | 2002 |
| Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms I Stalmans, YS Ng, R Rohan, M Fruttiger, A Bouché, A Ÿuce, H Fujisawa, ... The Journal of clinical investigation 109 (3), 327-336, 2002 | 658 | 2002 |
| Endothelium‐specific platelet‐derived growth factor‐B ablation mimics diabetic retinopathy M Enge, M Bjarnegård, H Gerhardt, E Gustafsson, M Kalén, N Asker, ... The EMBO journal, 2002 | 479 | 2002 |
| Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization HP Hammes, M Brownlee, A Jonczyk, A Sutter, KT Preissner Nature medicine 2 (5), 529-533, 1996 | 462 | 1996 |
| Diabetic retinopathy: targeting vasoregression HP Hammes, Y Feng, F Pfister, M Brownlee Diabetes 60 (1), 9, 2011 | 436 | 2011 |
| Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy HP Hammes, J Lin, P Wagner, Y Feng, F Vom Hagen, T Krzizok, ... Diabetes 53 (4), 1104-1110, 2004 | 419 | 2004 |
| Carnosine as a Protective Factor in Diabetic Nephropathy: Association With a Leucine Repeat of the Carnosinase Gene CNDP1 B Janssen, D Hohenadel, P Brinkkoetter, V Peters, N Rind, C Fischer, ... Diabetes 54 (8), 2320-2327, 2005 | 377 | 2005 |
| Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease J Spranger, M Osterhoff, M Reimann, M Mohlig, M Ristow, MK Francis, ... Diabetes 50 (12), 2641-2645, 2001 | 374 | 2001 |
| Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes HP Hammes, HJ Federoff, M Brownlee Molecular Medicine 1, 527-534, 1995 | 344 | 1995 |
| Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans M Morcos, X Du, F Pfisterer, H Hutter, AAR Sayed, P Thornalley, N Ahmed, ... Aging cell 7 (2), 260-269, 2008 | 331 | 2008 |
| Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. HP Hammes, J Lin, RG Bretzel, M Brownlee, G Breier Diabetes 47 (3), 401-406, 1998 | 295 | 1998 |
| ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD-summary. L Ryden, PJ Grant, SD Anker, C Berne, F Cosentino, N Danchin, ... Diabetes and Vascular Disease Research 11 (3), 2014 | 288* | 2014 |
| High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A D Yao, T Taguchi, T Matsumura, R Pestell, D Edelstein, I Giardino, ... Journal of Biological Chemistry 282 (42), 31038-31045, 2007 | 286 | 2007 |
Klaus T. PreissnerProfessor for Biochemistry and PathobiochemistryBestätigte E-Mail-Adresse bei biochemie.med.uni-giessen.de
